A randomized, placebo‐controlled crossover trial of phentermine‐topiramate ER in patients with binge‐eating disorder and bulimia nervosa
Debra L. Safer(Stanford University), Thomas Najarian(Orthopaedic Specialty Institute), Jason Bentley(Stanford Medicine), Shebani Sethi(Stanford Health Care), Sarah Pajarito(Wolters Kluwer Health), Hannah Toyama(Stanford University), Sarah Adler(Stanford University)
Cited by 67
Related Papers
A Therapeutic Relational Agent for Reducing Problematic Substance Use (Woebot): Development and Usability Study
|Journal of Medical Internet Research|2021|257
Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial
|Psychiatry Research|2024|129
What variables are associated with successful weight loss outcomes for bariatric surgery after 1 year?
|Surgery for Obesity and Related Diseases|2014|100
A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemic
|Drug and Alcohol Dependence|2021|92
Ketogenic diet as a metabolic treatment for mental illness
|Current Opinion in Endocrinology Diabetes and Obesity|2020|82